| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10486433 | Value in Health | 2011 | 9 Pages |
Abstract
Use of TIDI during the NICE appraisal of tumor necrosis factor-alpha inhibitors (in psoriatic arthritis) successfully demonstrated its ability to facilitate critiques of the decision models by decision makers.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sylwia PhD, Hayley E. PhD, Monica C.W. MSc, Nicola J. PhD, Neil PhD, Hazel MSc, Keith R. PhD, David J. PhD, Alex J. PhD,